Substance P/Neurokinin1 Receptor Antagonists - Index

Medications listed in the tables and non-FDA approved indications included in these retrospective criteria are not indicative of Texas Vendor Drug Program formulary coverage.

• Revision history
  • Oct. 24, 2024
  • Oct. 21, 2022
  • Sept. 2020
  • Sept. 2018
  • Sept. 2016
  • May 2015
  • Aug. 2013
  • June 2013
  • Sept. 2011
  • Oct. 2009
  • Feb. 2006
  • Jan. 2006
  • Dec. 2003 (initially developed)